Response: Maraviroc intensification and microbial translocation.
Department of Medicine, University of California, San Francisco, San Francisco, CA.
Peter W
PW
Hunt
Michael M
MM
Lederman
Steven G
SG
Deeks
D015496:CD4-Positive T-Lymphocytes / Q000276:immunology*; D003510:Cyclohexanes / Q000627:therapeutic use*; D005260:Female; D006086:Graft vs Host Disease / Q000276:immunology*; D015658:HIV Infections / Q000276:immunology*; D015497:HIV-1 / Q000276:immunology*; D006801:Humans; D008297:Male; D014230:Triazoles / Q000627:therapeutic use*; D019562:Viral Load / Q000187:drug effects*
D003510:Cyclohexanes; D014230:Triazoles